Xoma reported $-2065000 in EBIT for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebit Change
Abbvie ABBV:US $ 5029M 601M
Agenus AGEN:US $ -35997000 20.08M
Agios Pharmaceuticals AGIO:US $ -101145000 3.68M
Ardelyx ARDX:US $ -27807000 4.87M
Biomarin Pharmaceutical BMRN:US $ 29.33M 95.21M
Bluebird Bio BLUE:US $ -120346000 138.95M
Celldex Therapeutics CLDX:US $ -23257000 2.92M
Chimerix CMRX:US -24771000 14.76M
Curis CRIS:US $ -15133000 2.57M
Eli Lilly And LLY:US $ 2569.9M 171.6M
Emergent Biosolutions EBS:US $ 6.4M 312.7M
Epizyme EPZM:US $ -50926000 360K
Intercept Pharmaceuticals ICPT:US $ -10272000 10.59M
Life Technologies LIFE:US $ -12378000 3.74M
Macrogenics MGNX:US $ -66638000 8.4M
Novartis NOVN:VX 3.15B 266M
Novartis NVS:US 3.15B 266M
Pfizer PFE:US $ 9995M 4136M
Prothena PRTA:US -37944000 4.85M
Regeneron Pharmaceuticals REGN:US $ 1286.6M 1353.1M
Teva Pharmaceutical Industries TEVA:US 789M 182M
Xoma XOMA:US $ -2065000 32.43M
YTE INCY:US $ 127.66M 7.71M